Buy & Sell CVS Health Corp (CVS) – CVS Health Corp Price Today
Aura AI Summary
Key Stats
- $118.99BMarket Cap
- HealthSector
- -14.18%3M Drawdown
- $185.54BEnterprise Value
- 2.85%Dividend Yield
- 80 daysTypical Hold Time
CVS Health Corp (CVS) is currently valued at a market capitalization of $118.99B, with an enterprise value of $185.54B. Over the past 52 weeks, CVS Health Corp has traded between a low of $58.75 and a high of $98.11, highlighting its annual price range. Over the past three months, CVS Health Corp has recorded a drawdown of -14.18%, reflecting recent price volatility. CVS Health Corp offers a dividend yield of 2.85%, with the most recent dividend of $0.67 paid on 23 Apr 26. On average, investors hold CVS Health Corp for approximately 80 days, indicating typical investor behavior on the platform.
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Most Recent News
SpaceX IPO could trigger up to $27B in forced ETF buying due to Nasdaq rule changes, sparking potential lawsuits.
SpaceX's upcoming IPO may cause forced ETF buying of $22-$27 billion as Nasdaq changes rules to fast-track the company's index inclusion. The Nasdaq 100 now allows new companies to join within 15 days if their market cap ranks in the top 40, removing...

Global Bioprocess Automation Software market to reach $6.19B by 2035 with 14% CAGR, driven by personalized medicine and scalable production.
The global Bioprocess Automation Software market, valued at $1.67 billion in 2025, is projected to grow to $6.19 billion by 2035 at a 14% CAGR. This growth is fueled by the increasing demand for personalized medicine, flexible manufacturing processes...

Microneedle drug delivery market to double to $14.37B by 2035, driven by pain-free therapies and vaccine tech.
The global microneedle drug delivery systems market is projected to grow from $7.04 billion in 2025 to $14.37 billion by 2035, at a CAGR of 7.4%. Growth is fueled by rising demand for minimally invasive, pain-free, and self-administered drug delivery...
